{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-24-000044","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2024-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.528389+00:00","generated_at":"2026-06-01T07:02:46.789525+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"McKesson elects Deborah Dunsire to board; two directors to step down at 2024 annual meeting","bullets":["Deborah Dunsire, former CEO of H. Lundbeck, elected to McKesson board effective June 3, 2024; will serve on Compensation/Talent and Finance committees.","Linda Mantia (no longer independent) and Susan Salka (served nearly 10 years) will not stand for re-election at the 2024 annual meeting.","After the annual meeting, the board will be reduced to 11 members, 10 of whom are independent.","Dunsire brings over 30 years of experience in biopharmaceutical, oncology, and specialty industries."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-24-000044","json":"https://secwatch.observer/filing/0000927653-24-000044.json","markdown":"https://secwatch.observer/filing/0000927653-24-000044.md","text":"https://secwatch.observer/filing/0000927653-24-000044.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000044/0000927653-24-000044-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000044/mck-20240528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:02:46.789525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c2cc0c6b8","claim":"Susan R. Salka departed as Director at MCKESSON CORP.","evidence_excerpt":"Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000044/0000927653-24-000044-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"acf3d1b4df","claim":"Deborah Dunsire was elected as Director at MCKESSON CORP.","evidence_excerpt":"On May 31, 2024, the Board of Directors (“Board”) of McKesson Corporation (“Corporation”) elected Deborah Dunsire, M.D. as a director of the Corporation and appointed her to the Board’s Compensation and Talent Committee and Finance Committee, effective June 3, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000044/0000927653-24-000044-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f8b03051ca","claim":"Linda Mantia departed as Director at MCKESSON CORP.","evidence_excerpt":"Linda Mantia and Susan R. Salka will not be standing for re-election at the Corporation’s 2024 annual meeting of shareholders (“Annual Meeting”), and their terms will expire effective at the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000092765324000044/0000927653-24-000044-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}